{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:08:05Z","timestamp":1769166485879,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01-HL114471"],"award-info":[{"award-number":["P01-HL114471"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR003017"],"award-info":[{"award-number":["UL1TR003017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glucocorticoids (GCs) and \u03b2<jats:sub>2<\/jats:sub>-adrenergic receptor (\u03b2<jats:sub>2<\/jats:sub>AR) agonists improve asthma outcomes in most patients. GCs also modulate gene expression in human airway smooth muscle (HASM), thereby attenuating airway inflammation and airway hyperresponsiveness that define asthma. Our previous studies showed that the pro-fibrotic cytokine, transforming growth factor- \u03b21 (TGF-\u03b21) increases phosphodiesterase 4D (PDE4D) expression that attenuates agonist-induced levels of intracellular cAMP. Decreased cAMP levels then diminishes \u03b2<jats:sub>2<\/jats:sub> agonist-induced airway relaxation. In the current study, we investigated whether glucocorticoids reverse TGF-\u03b21-effects on \u03b2<jats:sub>2<\/jats:sub>-agonist-induced bronchodilation and modulate <jats:italic>pde4d<\/jats:italic> gene expression in HASM. Dexamethasone (DEX) reversed TGF-\u03b21 effects on cAMP levels induced by isoproterenol (ISO). TGF-\u03b21 also attenuated G protein-dependent responses to cholera toxin (CTX), a G<jats:sub>\u03b1s<\/jats:sub> stimulator downstream from the \u03b2<jats:sub>2<\/jats:sub>AR receptor. Previously, we demonstrated that TGF-\u03b21 treatment increased \u03b2<jats:sub>2<\/jats:sub>AR phosphorylation to induce hyporesponsiveness to a \u03b2<jats:sub>2<\/jats:sub> agonist. Our current data shows that expression of <jats:italic>grk2\/3<\/jats:italic>, kinases associated with attenuation of \u03b2<jats:sub>2<\/jats:sub>AR function, are not altered with TGF-\u03b21 stimulation. Interestingly, DEX also attenuated TGF-\u03b21-induced <jats:italic>pde4d<\/jats:italic> gene expression. These data suggest that steroids may be an effective therapy for treatment of asthma patients whose disease is primarily driven by elevated TGF-\u03b21 levels.<\/jats:p>","DOI":"10.1186\/s12931-020-01522-w","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T15:04:55Z","timestamp":1602169495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dexamethasone rescues TGF-\u03b21-mediated \u03b22-adrenergic receptor dysfunction and attenuates phosphodiesterase 4D expression in human airway smooth muscle cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Elena","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie A.","family":"Ojiaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoyuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Deeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Reynold A.","family":"Panettieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Koziol-White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"1522_CR1","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1164\/ajrccm.158.supplement_2.13tac170","volume":"158","author":"DS Postma","year":"1998","unstructured":"Postma DS, Kerstjens HA. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:S187\u201392.","journal-title":"Am J Respir Crit Care Med"},{"key":"1522_CR2","doi-asserted-by":"publisher","first-page":"23065","DOI":"10.1074\/jbc.M114.557652","volume":"289","author":"SJ Morgan","year":"2014","unstructured":"Morgan SJ, Deshpande DA, Tiegs BC, Misior AM, Yan H, Hershfeld AV, Rich TC, Panettieri RA, An SS, Penn RB. \u03b2-agonist-mediated relaxation of airway smooth muscle is protein kinase A-dependent. J Biol Chem. 2014;289:23065\u201374.","journal-title":"J Biol Chem"},{"key":"1522_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/thx.50.5.497","volume":"50","author":"DM Newnham","year":"1995","unstructured":"Newnham DM, Grove A, McDevitt DG, Lipworth BJ. Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. Thorax. 1995;50:497\u2013504.","journal-title":"Thorax"},{"key":"1522_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.7326\/0003-4819-144-12-200606200-00126","volume":"144","author":"SR Salpeter","year":"2006","unstructured":"Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144:904\u201312.","journal-title":"Ann Intern Med"},{"key":"1522_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1124\/pr.111.004580","volume":"64","author":"M Cazzola","year":"2012","unstructured":"Cazzola M, Page CP, Calzetta L, Matera MG. Pharmacology and therapeutics of bronchodilators. Pharmacol Rev. 2012;64:450\u2013504.","journal-title":"Pharmacol Rev"},{"key":"1522_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1465-9921-6-107","volume":"6","author":"S Haney","year":"2005","unstructured":"Haney S, Hancox RJ. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial. Respir Res. 2005;6:107.","journal-title":"Respir Res"},{"key":"1522_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1183\/09031936.03.00067503","volume":"21","author":"JM Wraight","year":"2003","unstructured":"Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR. Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J. 2003;21:810\u20135.","journal-title":"Eur Respir J"},{"key":"1522_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1164\/ajrccm.156.3.9610051","volume":"156","author":"DH Yates","year":"1997","unstructured":"Yates DH, Worsdell M, Barnes PJ. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma. Am J Respir Crit Care Med. 1997;156:988\u201391.","journal-title":"Am J Respir Crit Care Med"},{"key":"1522_CR9","first-page":"195","volume":"14","author":"RP Yim","year":"2013","unstructured":"Yim RP, Koumbourlis AC. Tolerance & resistance to \u03b22-agonist bronchodilators. Paediatr Respir Rev. 2013;14:195\u20138.","journal-title":"Paediatr Respir Rev"},{"key":"1522_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1165\/rcmb.2017-0247OC","volume":"58","author":"CA Ojiaku","year":"2018","unstructured":"Ojiaku CA, Cao G, Zhu W, Yoo EJ, Shumyatcher M, Himes BE, An SS, Panettieri RA Jr. TGF-\u03b21 evokes human airway smooth muscle cell shortening and Hyperresponsiveness via Smad3. Am J Respir Cell Mol Biol. 2018;58:575\u201384.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1522_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1165\/rcmb.2018-0301OC","volume":"61","author":"CA Ojiaku","year":"2019","unstructured":"Ojiaku CA, Chung E, Parikh V, Williams JK, Schwab A, Fuentes AL, Corpuz ML, Lui V, Paek S, Bexiga NM, et al. Transforming growth factor-\u03b21 decreases \u03b2(2)-agonist-induced relaxation in human airway smooth muscle. Am J Respir Cell Mol Biol. 2019;61:209\u201318.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1522_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1513\/pats.200705-054VS","volume":"5","author":"RB Penn","year":"2008","unstructured":"Penn RB, Benovic JL. Regulation of heterotrimeric G protein signaling in airway smooth muscle. Proc Am Thorac Soc. 2008;5:47\u201357.","journal-title":"Proc Am Thorac Soc"},{"key":"1522_CR13","first-page":"3","volume":"332","author":"LM Luttrell","year":"2006","unstructured":"Luttrell LM. Transmembrane signaling by G protein-coupled receptors. Methods Mol Biol. 2006;332:3\u201349.","journal-title":"Methods Mol Biol"},{"key":"1522_CR14","first-page":"179","volume":"133","author":"K Bharati","year":"2011","unstructured":"Bharati K, Ganguly NK. Cholera toxin: a paradigm of a multifunctional protein. Indian J Med Res. 2011;133:179\u201387.","journal-title":"Indian J Med Res"},{"key":"1522_CR15","doi-asserted-by":"publisher","first-page":"L924","DOI":"10.1152\/ajplung.00463.2004","volume":"288","author":"CA Hirshman","year":"2005","unstructured":"Hirshman CA, Zhu D, Pertel T, Panettieri RA, Emala CW. Isoproterenol induces actin depolymerization in human airway smooth muscle cells via activation of an Src kinase and GS. Am J Physiol Lung Cell Mol Physiol. 2005;288:L924\u201331.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1522_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1677\/joe.1.05962","volume":"185","author":"MF Iu","year":"2005","unstructured":"Iu MF, Kaji H, Sowa H, Naito J, Sugimoto T, Chihara K. Dexamethasone suppresses Smad3 pathway in osteoblastic cells. J Endocrinol. 2005;185:131\u20138.","journal-title":"J Endocrinol"},{"key":"1522_CR17","doi-asserted-by":"publisher","first-page":"11776","DOI":"10.1073\/pnas.96.21.11776","volume":"96","author":"CZ Song","year":"1999","unstructured":"Song CZ, Tian X, Gelehrter TD. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci U S A. 1999;96:11776\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1522_CR18","doi-asserted-by":"publisher","first-page":"C329","DOI":"10.1152\/ajpcell.1989.256.2.C329","volume":"256","author":"RA Panettieri","year":"1989","unstructured":"Panettieri RA, Murray RK, DePalo LR, Yadvish PA, Kotlikoff MI. A human airway smooth muscle cell line that retains physiological responsiveness. Am J Phys. 1989;256:C329\u201335.","journal-title":"Am J Phys"},{"key":"1522_CR19","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1111\/bph.13542","volume":"173","author":"CJ Koziol-White","year":"2016","unstructured":"Koziol-White CJ, Yoo EJ, Cao G, Zhang J, Papanikolaou E, Pushkarsky I, Andrews A, Himes BE, Damoiseaux RD, Liggett SB, et al. Inhibition of PI3K promotes dilation of human small airways in a rho kinase-dependent manner. Br J Pharmacol. 2016;173:2726\u201338.","journal-title":"Br J Pharmacol"},{"key":"1522_CR20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jaci.2015.02.006","volume":"135","author":"GD Albano","year":"2015","unstructured":"Albano GD, Zhao J, Etling EB, Park SY, Hu H, Trudeau JB, Profita M, Wenzel SE. IL-13 desensitizes \u03b22-adrenergic receptors in human airway epithelial cells through a 15-lipoxygenase\/G protein receptor kinase 2 mechanism. J Allergy Clin Immunol. 2015;135:1144\u201353 e1141\u20131149.","journal-title":"J Allergy Clin Immunol"},{"key":"1522_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/rr12","volume":"1","author":"Y Amrani","year":"2000","unstructured":"Amrani Y, Chen H, Panettieri RA Jr. Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma? Respir Res. 2000;1:49\u201353.","journal-title":"Respir Res"},{"key":"1522_CR22","first-page":"L491","volume":"275","author":"JD Laporte","year":"1998","unstructured":"Laporte JD, Moore PE, Panettieri RA, Moeller W, Heyder J, Shore SA. Prostanoids mediate IL-1beta-induced beta-adrenergic hyporesponsiveness in human airway smooth muscle cells. Am J Phys. 1998;275:L491\u2013501.","journal-title":"Am J Phys"},{"key":"1522_CR23","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/sj.bjp.0702193","volume":"125","author":"L Pang","year":"1998","unstructured":"Pang L, Holland E, Knox AJ. Role of cyclo-oxygenase-2 induction in interleukin-1beta induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline. Br J Pharmacol. 1998;125:1320\u20138.","journal-title":"Br J Pharmacol"},{"key":"1522_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1096\/fj.13-240226","volume":"28","author":"DA Deshpande","year":"2014","unstructured":"Deshpande DA, Yan H, Kong KC, Tiegs BC, Morgan SJ, Pera T, Panettieri RA, Eckhart AD, Penn RB. Exploiting functional domains of GRK2\/3 to alter the competitive balance of pro- and anticontractile signaling in airway smooth muscle. FASEB J. 2014;28:956\u201365.","journal-title":"FASEB J"},{"key":"1522_CR25","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.1021\/bi801056w","volume":"47","author":"KC Kong","year":"2008","unstructured":"Kong KC, Gandhi U, Martin TJ, Anz CB, Yan H, Misior AM, Pascual RM, Deshpande DA, Penn RB. Endogenous Gs-coupled receptors in smooth muscle exhibit differential susceptibility to GRK2\/3-mediated desensitization. Biochemistry. 2008;47:9279\u201388.","journal-title":"Biochemistry"},{"key":"1522_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cei.13191","volume":"194","author":"L Chachi","year":"2018","unstructured":"Chachi L, Alzahrani A, Koziol-White C, Biddle M, Bagadood R, Panettieri RA Jr, Bradding P, Amrani Y. Increased \u03b22-adrenoceptor phosphorylation in airway smooth muscle in severe asthma: possible role of mast cell-derived growth factors. Clin Exp Immunol. 2018;194:253\u20138.","journal-title":"Clin Exp Immunol"},{"key":"1522_CR27","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.jaci.2004.04.041","volume":"114","author":"PH Howarth","year":"2004","unstructured":"Howarth PH, Knox AJ, Amrani Y, Tliba O, Panettieri RA Jr, Johnson M. Synthetic responses in airway smooth muscle. J Allergy Clin Immunol. 2004;114:S32\u201350.","journal-title":"J Allergy Clin Immunol"},{"key":"1522_CR28","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jaci.2010.02.007","volume":"125","author":"G Nino","year":"2010","unstructured":"Nino G, Hu A, Grunstein JS, Grunstein MM. Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure. J Allergy Clin Immunol. 2010;125:1020\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"1522_CR29","first-page":"L405","volume":"276","author":"K Hotta","year":"1999","unstructured":"Hotta K, Emala CW, Hirshman CA. TNF-alpha upregulates Gialpha and Gqalpha protein expression and function in human airway smooth muscle cells. Am J Phys. 1999;276:L405\u201311.","journal-title":"Am J Phys"},{"key":"1522_CR30","doi-asserted-by":"publisher","first-page":"e26628","DOI":"10.1371\/journal.pone.0026628","volume":"6","author":"M Huntgeburth","year":"2011","unstructured":"Huntgeburth M, Tiemann K, Shahverdyan R, Schluter KD, Schreckenberg R, Gross ML, Modersheim S, Caglayan E, Muller-Ehmsen J, Ghanem A, et al. Transforming growth factor beta(1) oppositely regulates the hypertrophic and contractile response to beta-adrenergic stimulation in the heart. PLoS One. 2011;6:e26628.","journal-title":"PLoS One"},{"key":"1522_CR31","first-page":"1084","volume":"122","author":"BM Wagener","year":"2015","unstructured":"Wagener BM, Roux J, Carles M, Pittet J-F. Synergistic inhibition of \u03b22-adrenergic receptor\u2013mediated alveolar epithelial fluid transport by Interleukin-8 and transforming growth factor-\u03b2. Anesthesiol J Am Soc Anesthesiol. 2015;122:1084\u201392.","journal-title":"Anesthesiol J Am Soc Anesthesiol"},{"key":"1522_CR32","doi-asserted-by":"publisher","first-page":"9528","DOI":"10.1074\/jbc.M413078200","volume":"280","author":"C Krasel","year":"2005","unstructured":"Krasel C, B\u00fcnemann M, Lorenz K, Lohse MJ. Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem. 2005;280:9528\u201335.","journal-title":"J Biol Chem"},{"key":"1522_CR33","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1074\/jbc.M506576200","volume":"281","author":"SK Shenoy","year":"2006","unstructured":"Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, Lefkowitz RJ. Beta-arrestin-dependent, G protein-independent ERK1\/2 activation by the beta2 adrenergic receptor. J Biol Chem. 2006;281:1261\u201373.","journal-title":"J Biol Chem"},{"key":"1522_CR34","first-page":"631","volume":"41","author":"Q Song","year":"2018","unstructured":"Song Q, Ji Q, Li Q. The role and mechanism of \u03b2-arrestins in cancer invasion and metastasis (review). Int J Mol Med. 2018;41:631\u20139.","journal-title":"Int J Mol Med"},{"key":"1522_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jaci.2008.07.040","volume":"122","author":"PR Cooper","year":"2008","unstructured":"Cooper PR, Panettieri RA Jr. Steroids completely reverse albuterol-induced beta(2)-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol. 2008;122:734\u201340.","journal-title":"J Allergy Clin Immunol"},{"key":"1522_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099625","volume":"9","author":"BE Himes","year":"2014","unstructured":"Himes BE, Jiang X, Wagner P, Hu R, Wang Q, Klanderman B, Whitaker RM, Duan Q, Lasky-Su J, Nikolos C, et al. RNA-Seq transcriptome profiling identifies CRISPLD2 as a glucocorticoid responsive gene that modulates cytokine function in airway smooth muscle cells. PLoS One. 2014;9:e99625.","journal-title":"PLoS One"},{"key":"1522_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1165\/rcmb.2007-0171OC","volume":"38","author":"CK Billington","year":"2008","unstructured":"Billington CK, Le Jeune IR, Young KW, Hall IP. A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells. Am J Respir Cell Mol Biol. 2008;38:1\u20137.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1522_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020000","volume":"6","author":"T Trian","year":"2011","unstructured":"Trian T, Burgess JK, Niimi K, Moir LM, Ge Q, Berger P, Liggett SB, Black JL, Oliver BG. \u03b22-agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D. PLoS One. 2011;6:e20000.","journal-title":"PLoS One"},{"key":"1522_CR39","doi-asserted-by":"crossref","unstructured":"Niimi K, Ge Q, Moir LM, Ammit AJ, Trian T, Burgess JK, Black JL, Oliver BG: Beta2-agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers. Am J Physiol Lung Cell Mol Physiol 2012, 302:L334\u2013L342.","DOI":"10.1152\/ajplung.00163.2011"},{"key":"1522_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.bjp.0704743","volume":"136","author":"SJ MacKenzie","year":"2002","unstructured":"MacKenzie SJ, Baillie GS, McPhee I, MacKenzie C, Seamons R, McSorley T, Millen J, Beard MB, van Heeke G, Houslay MD. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in upstream conserved region 1 (UCR1). Br J Pharmacol. 2002;136:421\u201333.","journal-title":"Br J Pharmacol"},{"key":"1522_CR41","doi-asserted-by":"crossref","unstructured":"Bourke JE, Li X, Foster SR, Wee E, Dagher H, Ziogas J, Harris T, Bonacci JV, Stewart AG. Collagen remodelling by airway smooth muscle is resistant to steroids and \u03b2<sub>2<\/sub>\u2212agonists. 2011;37:173\u201382.","DOI":"10.1183\/09031936.00008109"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-020-01522-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T23:32:05Z","timestamp":1633649525000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01522-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01522-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human tissue was acquired through the National Disease Research Interchange (NDRI) and the International Institute for the Advancement of Medicine (IIAM) and was obtained commercially from anonymous donors and according to the procedures approved by the Rutgers University IRB. As such, the human tissue is exempt from requiring IRB approval. Although information concerning the cause of death, gender, race, age, body weight & height of the donor is available, there are no unique identifiers that can link the subject\u2019s identification to the tissue sample.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}